Filing Details

Accession Number:
0001181431-13-055307
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-10-28 16:55:18
Reporting Period:
2013-10-23
Filing Date:
2013-10-28
Accepted Time:
2013-10-28 16:55:18
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1011835 Medivation Inc. MDVN Pharmaceutical Preparations (2834) 133863260
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1529371 Cheryl Cohen C/O Medivation, Inc.
525 Market St., 36Th Floor
San Francisco CA 94105
Chief Commercial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-10-23 25,000 $9.61 50,439 No 4 M Direct
Common Stock Disposition 2013-10-23 25,000 $63.05 25,439 No 4 S Direct
Common Stock Acquisiton 2013-10-24 25,000 $9.61 50,439 No 4 M Direct
Common Stock Disposition 2013-10-24 23,000 $65.40 27,439 No 4 S Direct
Common Stock Disposition 2013-10-24 2,000 $66.02 25,439 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2013-10-23 25,000 $0.00 25,000 $9.61
Common Stock Stock Option (Right to Buy) Disposition 2013-10-24 25,000 $0.00 25,000 $9.61
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
350,000 2021-09-15 No 4 D Direct
325,000 2021-09-15 No 4 D Direct
Footnotes
  1. The shares were sold pursuant to a 10b5-1 Plan.
  2. The shares were sold at prices ranging from $63.03 to $63.075. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
  3. The shares subject to the option shall become vested according to the following schedule: 25% of the shares subject to the option (rounded down to the next whole number of shares) shall vest on September 15, 2012, and 1/48th of the shares subject to the option (rounded down to the next whole number of shares) shall vest of the first day of each full month thereafter.
  4. The shares were sold at prices ranging from $65.00 to $65.87. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.